Current position:Home >Product >
Ethanamine, 2-[(3-pyridazinylmethyl)thio]-, compd. with 2,4,6-trinitrophenol (1:2)
Ethanamine, 2-[(3-pyridazinylmethyl)thio]-, compd. with 2,4,6-trinitrophenol (1:2)(38585-43-2)
- Name: Ethanamine, 2-[(3-pyridazinylmethyl)thio]-, compd. with 2,4,6-trinitrophenol (1:2)
- Synonyms:
- Molecular Formula:C7H11N3S.2C6H3N3O7
- Molecular Weight:
- CAS Registry Number:38585-43-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 385826-19-7/Butanoic acid, 2-(2-furanylmethylene)-3-oxo-, 1,1-dimethylethyl ester, (2Z)-
- 385826-24-4/2-Cyclohexene-1-carboxylic acid, 1-acetyl-4-oxo-6-phenyl-, 1,1-dimethylethyl ester, (1R,6R)-rel-
- 38583-07-2/1H-Benzimidazolium, 1,3-dimethyl-2-naphtho[2,1-b]furan-2-yl-, iodide
- 385833-81-8/L-Valine, L-leucyl-L-arginyl-L-leucyl-L-cysteinyl-L-valyl-L-glutaminyl-L-seryl-L-threonyl- L-histidyl-
- 385834-51-5/L-Phenylalanine, L-a-aspartyl-L-arginyl-L-alanyl-L-histidyl-L-tyrosyl-L-asparaginyl-L-isoleucyl -L-valyl-L-threonyl-
- 385834-56-0/L-Methionine, L-isoleucyl-L-arginyl-L-threonyl-L-leucyl-L-a-glutamyl-L-a-aspartyl-L-leucyl- L-leucyl-
- 385834-57-1/L-Histidine, L-leucyl-L-arginyl-L-leucyl-L-cysteinyl-L-valyl-L-glutaminyl-L-seryl-L-threonyl-
- 385834-64-0/L-Leucine, L-valyl-L-a-aspartyl-L-isoleucyl-L-arginyl-L-threonyl-L-leucyl-L-a-glutamyl-L- a-aspartyl-L-leucyl-
- 385837-48-9/4-Pentenethioamide, 2-[(S)-cyclohexylsulfinyl]-N,N-dimethyl-, (2S)-
- 385837-96-7/Ethenamine, 2-[(S)-cyclohexylsulfinyl]-N,N-dimethyl-1-(2-propenylthio)-, (1Z)-
- 385841-32-7/Propanamide, 2-bromo-N-1-cyclohexen-1-yl-N-(phenylmethyl)-
- 38584-17-7/Benzothiazolium, 2-[[5-[(5-ethoxy-3-ethyl-6-methyl-2(3H)-benzothiazolylidene)ethylidene]- 4-oxo-3-phenyl-2-thiazolidinylidene]methyl]-3-ethyl-, iodide
- 385843-42-5/Acetamide, N-(4-chlorophenyl)-N-2-propenyl-
- 385843-65-2/4-Oxazolidinone, 3-ethyl-5-[(9-ethyl-9H-carbazol-3-yl)methylene]-2-thioxo-
- 385843-91-4/Piperazine, 1-[4-(1-naphthalenyl)butyl]-, dihydrochloride
- 385843-95-8/Piperazine, 1-[2-(4-fluorophenyl)-2-(4-methyl-1-piperazinyl)ethyl]-4-[4-(1-naphthalen yl)butyl]-
- 385844-19-9/4-Piperidinol, 4-[1-(4-fluorophenyl)-2-[4-[4-(1-naphthalenyl)butyl]-1-piperazinyl]ethyl]-1- methyl-
- 385844-23-5/Piperazine, 1-[2-(4-fluorophenyl)-2-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)ethyl]-4-[ 4-(1-naphthalenyl)butyl]-
- 385844-25-7/Piperazine, 1-[(4-fluorophenyl)(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)acetyl]-4-[4-(1 -naphthalenyl)butyl]-
- 38585-43-2/Ethanamine, 2-[(3-pyridazinylmethyl)thio]-, compd. with 2,4,6-trinitrophenol (1:2)
- 38585-44-3/Ethanamine, 2-[(1H-benzimidazol-2-ylmethyl)thio]-, dihydrobromide
- 38585-45-4/Ethanamine, 2-[[(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-yl)methyl]thio]-, dihydrobromide
- 38585-46-5/Ethanamine, 2-[[2-(1H-imidazol-4-yl)ethyl]thio]-, compd. with 2,4,6-trinitrophenol (1:2)
- 38585-50-1/1-Propanamine, 3-(1H-imidazol-2-ylthio)-, dihydrobromide
- 38585-51-2/1-Propanamine, 3-[(1-methyl-1H-imidazol-2-yl)thio]-, dihydrobromide
- 38585-52-3/1-Propanamine, 3-(2-thiazolylthio)-, dihydrobromide
- 38585-56-7/1H-Isoindole-1,3(2H)-dione, 2-[3-[(4-methyl-2-oxazolyl)thio]propyl]-
- 38585-68-1/1H-Imidazole-4,5-dimethanol, monohydrochloride
- 38586-05-9/Benzeneacetonitrile, a-(phenylmethoxy)-
- 38586-06-0/Benzeneacetonitrile, a-(2-propenyloxy)-